A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer

被引：0
|
作者：
Yoshiki Hirooka
Hideki Kasuya
Takuya Ishikawa
Hiroki Kawashima
Eizaburo Ohno
Itzel B. Villalobos
Yoshinori Naoe
Toru Ichinose
Nobuto Koyama
Maki Tanaka
Yasuhiro Kodera
Hidemi Goto
机构：
[1] Nagoya University Hospital,Department of Endoscopy
[2] Nagoya University Graduate School of Medicine,Cancer Immune Therapy Research Center
[3] Nagoya University Graduate School of Medicine,Department of Gastroenterology
[4] Takara Bio Inc.,Department of Surgery II
[5] Nagoya University Graduate School of Medicine,undefined
来源：
BMC Cancer | / 18卷
关键词：
Pancreatic cancer; Oncolytic virus; HF10; EUS-guidance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Evaluation of CHST15 Expression for Assessing the Tumor Progression and Overall Survival of EUS-Guided Intratumoral Chst15 Dsrna Injection in Patient With Unresectable Pancreatic Cancer
    Nishimura, Makoto
    Matsukawa, Miho
    Fujii, Yuko
    Matsuda, Yoko
    Yahagi, Naohisa
    GASTROINTESTINAL ENDOSCOPY, 2017, 85 (05) : AB334 - AB334
  • [32] Phase I study of intratumoral injection of talimogene laherparepvec for the treatment of advanced pancreatic cancer
    Runcie, Karie
    Bracero, Yadriel
    Samouha, Avishai
    Manji, Gulam
    Remotti, Helen E.
    Gonda, Tamas A.
    Saenger, Yvonne
    ONCOLOGIST, 2024,
  • [33] EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study
    Hecht, J. Randolph
    Farrell, James J.
    Senzer, Neil
    Nemunaitis, John
    Rosemurgy, Alexander
    Chung, Theodore
    Hanna, Nader
    Chang, Kenneth J.
    Javle, Milind
    Posner, Mitchell
    Waxman, Irving
    Reid, Anthony
    Erickson, Richard
    Canto, Marcia
    Chak, Amitabh
    Blatner, Gretta
    Kovacevic, Milan
    Thornton, Mark
    GASTROINTESTINAL ENDOSCOPY, 2012, 75 (02) : 332 - 338
  • [34] Tumor response from phase II study of combination treatment with intratumoral HF10, a replicationcompetent HSV-1 oncolytic virus, and ipilimumab in patients with stage IIIB, IIIC, or IV unresectable or metastatic melanoma
    Andtbacka, R.
    Ross, M.
    Agarwala, S. S.
    Taylor, M.
    Vetto, J.
    Neves, R. I.
    Daud, A.
    Khong, H.
    Ungerleider, R. S.
    Welden, S.
    Tanaka, M.
    Grossmann, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [35] Phase I trial of intratumoral therapy using HF10, an oncolytic HSV-1, demonstrates safety in HSV plus /HSV- patients with refractory and superficial cancers.
    Ferris, Robert L.
    Gross, Neil D.
    Nemunaitis, John J.
    Andtbacka, Robert Hans Ingemar
    Argiris, Athanassios
    Ohr, James
    Vetto, John T.
    Senzer, Neil N.
    Bedell, Cindi
    Ungerleider, Richard S.
    Tanaka, Maki
    Nishiyama, Yukihiro
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [36] Stereotactic ablative radiotherapy using EUS-guided fiducial placement for locally advanced pancreatic cancer: Early experience in a tertiary center
    Vinh-An Phan
    Hien Le
    Singhal, Nimit
    Nam Nguyen
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 206 - 206
  • [37] Gemcitabine, paclitaxel, and radiation for locally advanced pancreatic cancer: A phase I trial
    Safran, H
    Dipetrillo, T
    Iannitti, D
    Quirk, D
    Akerman, P
    Cruff, D
    Cioffi, W
    Shah, S
    Ramdin, N
    Rich, T
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (01): : 137 - 141
  • [38] Phase I trial of capecitabine and gemcitabine with radiotherapy in locally advanced pancreatic cancer
    Leong, T.
    Michael, M.
    Price, T.
    Ganju, V
    Strickland, A.
    Jefford, M.
    Muller, A.
    Ngan, S.
    Milner, A.
    Zalcberg, J.
    ANNALS OF ONCOLOGY, 2006, 17 : 34 - 34
  • [39] Phase I/II trial of hyperfractionated accelerated chemoradiotherapy for unresectable advanced pancreatic cancer
    Tsujie, Masanori
    Nakamori, Shoji
    Tanaka, Eiichi
    Nagano, Hiroaki
    Umeshita, Koji
    Dono, Keizo
    Sakon, Masato
    Inoue, Takehiro
    Inoue, Toshihiko
    Monden, Morito
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (08) : 504 - 510
  • [40] Phase I trial of the human immunodeficiency virus protease inhibitor Nelfinavir and chemoradiation for locally advanced pancreatic cancer
    Brunner, Thomas B.
    Geiger, Matthias
    Grabenbauer, Gerhard G.
    Lang-Welzenbach, Marga
    Mantoni, Tine S.
    Cavallaro, Alexander
    Sauer, Rolf
    Hohenberger, Werner
    McKenna, W. Gillies
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (16) : 2699 - 2706
12345